u/sigrid_kaufmann

the memo field matters on the chains that use one

Bacteriostatic water contains benzyl alcohol as a preservative, which is what makes repeated entry into the same vial reasonable. Plain sterile water has no preservative.

Disagree with the "more water is safer" framing. It is not safer, it is just a different number to divide by.

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

the starting dose is not meant to be the dose that works

Adding the one habit worth starting today: write the concentration on the vial.

A1c, CGM, or fingersticks — which are we discussing?

Agreed on the swirl. There is no reason to shake it and a good reason not to.

How long between the two A1c measurements?

What else is in the regimen?

Kept fingersticks alongside the sensor for two weeks to sanity-check it. Worth doing once.

503A is patient-specific, 503B is outsourcing facility, they are not the same thing

Those criteria were revised at renewal, so the version quoted upthread is out of date.

Correction: the starting dose is a tolerance step rather than a treatment dose. The distinction is the answer to the question above.

Not convinced comparison helps here. The people posting the fastest results are the tail of a distribution, not the middle.

What did the intake actually ask you?

screenshot the transaction hash, not the wallet balance

If your calculation produces a fraction of a unit, the concentration is wrong for your dose. Change the water volume until the numbers land on whole units.

That figure is the starting material purity, not the finished preparation potency. Two different tests.

10mg into 1mL is 10mg/mL, and 1.5mg of that is 15 units

Wrote the date on the vial as well as the concentration after losing track of which one was opened first.

Appetite change and weight change are different measurements on different timescales. The first is usually noticed first and the second lags it.

The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which ch

Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.

What did the denial actually say?

a U-100 syringe reads 100 units to the millilitre, every time

Cosigning the round-number approach. Reconstituting to something awkward is how you end up drawing 27.5 units at six in the morning.

Not quite. Bacteriostatic and sterile water are not interchangeable for a multi-draw vial, and the difference is the preservative.

Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.

the supplier cannot reverse it and neither can you

screenshot the transaction hash, not the wallet balance

Appetite change and weight change are different measurements on different timescales. The first is usually noticed first and the second lags it.

Bought small on anything without a testing history here. That rule has never once cost me anything.

Did you write the concentration on the vial?

Not convinced. Hypoglycaemia risk from this class alone is low; the risk you are describing comes from the combination.

goal weights chosen at week one are usually guesses

Yes — gas is the network’s, not the supplier’s, and conflating them produces a lot of unfair complaints.

This is the check that prevents the only genuinely unrecoverable mistake in this thread.

Week 7 for me was completely flat and I was convinced something was wrong. It was not. Month two was where everything happened.

Has your plan renewed since the last time you applied?

employer plans have their own criteria and their own appeals

the shortage list is the whole legal hinge and people skip it

A1c, CGM, or fingersticks — which are we discussing?